Working together to reduce the global burden of kidney cancer

Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.

Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.

2022 Global Patient Survey on Kidney Cancer Now Open

The International Kidney Cancer Coalition (IKCC) in partnership with patient organisations around the world have launched the 2022 Global Patient Survey. All patients, carers and survivors are encouraged to share their experiences and insights living with kidney cancer in the online survey.

Take the survey now

Highlights from the ESMO Congress 2022

The European Society of Medical Oncology (ESMO) congress was held in person (for the 1st time in 2 years) and virtually from 9-13 September 2022. The presentations are available to view on the ESMO website if you have previously logged in to the site. The International Kidney Cancer Coalition (IKCC) attended the scientific programme to keep abreast of the latest advances in the care and treatment of people with kidney cancer.

Read more

Mark your calendars 

The Global Kidney Cancer Summit 2022 will be held on 13 -15 October 2022.

We are excited to announce we are planning for an in-person meeting in Milan, Italy.
So many of us have missed being in person with the global kidney cancer community and the energy generated when we are all together. And while we have built and strengthened our connections digitally over the past two years, we’re looking forward to being together again.

Read more

Updates from IKCC

2 days ago
Please spare 10 minutes today to help us help you
What: 2022 Global #kidneycancer Patient Survey
Who: People living with kidney cancer, carers and survivors
When: Now! Survey will be open until 31 October
Where: https://t.co/Srv5cpFEu6 https://t.co/H1hxeczTUs
2 days ago
Excellent overview of personalized decision making for #kidneycancer from @katy_beckermann @VUMCHemOnc - highlights #IMDC criteria, pattern of metastatic spread, patient-level comorbidities. #GDUGU2022 @GreatDebatesCME https://t.co/pmCxjzDqxA
2 days ago
A broad overview on treatment sequences for refractory #kidneycancer from @bergsa83 newly @DanaFarber_GU - covering lenvatinib/everolimus, tivozanib, belzutifan, lenvatinib-pembro in previously treated disease and ongoing trials. Important to find effective treatments! #GDUGU2022 https://t.co/pxkJPZz8Xd
2 days ago
#KCRS22 Oral Abstract Session: @srviswanathan @DanaFarber analyses the epigenetic and transcriptional profiles of translocation #kidneycancer, identifying potential determinants of resistance to targeted therapies

Abstracts: https://t.co/riQSvP5Iep
https://t.co/uhaOhTZIsz https://t.co/r3oZS671ev

Did you know?

Kidney cancer is often found by accident.

Kidney cancer is the 12th most prevalent cancer worldwide.

About 59 per cent of kidney cancer cases occur in more developed countries.

Our Global Network

IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.

Explore Our Global Network

Join our mailing list

In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.

Sign up